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The S-nitrosation of mitochondrial proteins as a consequence
of NO metabolism is of physiological and pathological
signiﬁcance.WepreviouslydevelopedaMitoSNO(mitochondria-
targetedS-nitrosothiol)thatselectivelyS-nitrosatesmitochondrial
proteins. To identify these S-nitrosated proteins, here we have
developed a selective proteomic methodology, SNO-DIGE (S-
nitrosothiol difference in gel electrophoresis). Protein thiols
in control and MitoSNO-treated samples were blocked, then
incubated with copper(II) and ascorbate to selectively reduce
S-nitrosothiols. The samples were then treated with thiol-reactive
Cy3 (indocarbocyanine) or Cy5 (indodicarbocyanine) ﬂuorescent
tags,mixedtogetherandindividualproteinspotswereresolvedby
2D (two-dimensional) gel electrophoresis. Fluorescent scanning
of these gels revealed S-nitrosated proteins by an increase in Cy5
red ﬂuorescence, allowing for their identiﬁcation by MS. Parallel
analysis by Redox-DIGE enabled us to distinguish S-nitrosated
thiol proteins from those which became oxidized due to NO
metabolism.Weidentiﬁed13S-nitrosatedmitochondrialproteins,
and a further four that were oxidized, probably due to evanescent
S-nitrosation relaxing to a reversible thiol modiﬁcation. We
investigated the consequences of S-nitrosation for three of the
enzymes identiﬁed using SNO-DIGE (aconitase, mitochondrial
aldehydedehydrogenaseandα-ketoglutaratedehydrogenase)and
found that their activity was selectively and reversibly inhibited
by S-nitrosation. We conclude that the reversible regulation of
enzyme activity by S-nitrosation modiﬁes enzymes central to
mitochondrial metabolism, whereas identiﬁcation and functional
characterization of these novel targets provides mechanistic
insight into the potential physiological and pathological roles
played by this modiﬁcation. More generally, the development
of SNO-DIGE facilitates robust investigation of protein
S-nitrosation across the proteome.
Key words: difference in gel electrophoresis (DIGE),
mitochondria, nitric oxide (NO), redox signalling, S-nitrosation,
S-nitrosylation.
INTRODUCTION
Reversible S-nitrosation affects a number of mitochondrial
proteins and is thought to be a major way in which NO
metabolism modulates mitochondrial physiology and pathology
[1,2]. Within cells, mitochondria are exposed to signiﬁcant
concentrations of NO from NOSs (nitric oxide synthases),
resulting in substantial effects on mitochondrial respiration [3].
Although some mechanisms of NO action have been established,
such as its reversible active site inhibition of cytochrome c
oxidase, the breadth of protein targets of NO within mitochondria
is not well understood. In particular, the pathways by which NO
metabolism leads to protein S-nitrosation and the physiological
consequences of these modiﬁcations remain obscure [4,5].
Previous work has identiﬁed complex I as an important site
of mitochondrial S-nitrosation and, although this modiﬁcation
is known to affect its activity [2,6], a number of additional
mitochondrialproteinsarealsoS-nitrosated[6,7].Despitethis,the
identitiesoftheseadditionaltargetsandtheirfunctionalresponses
toS-nitrosationarepoorlyunderstood.Consequently,thereisstill
considerable uncertainty regarding the majority of mitochondrial
proteinsaffectedbyS-nitrosationandthefunctionalconsequences
of these modiﬁcations.
To investigate mitochondrial S-nitrosation, we developed a
MitoSNO (mitochondria-targeted S-nitrosothiol) that rapidly
accumulatesseveral-hundredfoldwithinenergizedmitochondria,
leading to the selective S-nitrosation of mitochondrial protein
thiols (Figure 1) [6]. MitoSNO consists of the well-characterized
NO donor SNAP (S-nitroso-N-acetylpenicillamine) conjugated
to a lipophilic TPP (triphenylphosphonium) cationic moiety.
The delocalized positive charge and lipophilic surface of TPP
allows MitoSNO to rapidly cross biological membranes and to
accumulate several hundred-fold within energized mitochondria
in vivo, driven by membrane potential across the mitochondrial
inner membrane. The local pH and reducing conditions then
allow for the selective transnitrosation of protein thiols sensitive
to S-nitrosation within mitochondria. We previously found
that MitoSNO only S-nitrosated a small proportion (∼1%)
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Figure 1 S-nitrosation of mitochondrial proteins by MitoSNO
According to the Nernst equation,lipophilic triphenylphosphoniumcations accumulate approx.
10-fold for every 60 mV of membrane potential ( ψ). With approximate values of  ψ in the
heart being 70 mV across the plasma membrane and 140 mV across the mitochondrial inner
membrane, these potential differences lead to an approx. 3000-fold accumulation of MitoSNO
within mitochondria. MitoSNO will S-nitrosate mitochondrial thiol proteins by transferring a
nitrosonium group (NO+) to protein thiolates.
of the mitochondrial protein thiols available, and these thiols
were present on a limited subset of mitochondrial proteins
[6]. These results suggest that the mitochondrial proteins S-
nitrosated by MitoSNO are those that are particularly susceptible
to S-nitrosation and are therefore candidates for the potential
consequent physiological response. Therefore identifying these
targets should open new insights into the physiological and
pathological roles of mitochondrial S-nitrosation.
Here we set out to identify those mitochondrial proteins, in
addition to complex I, that are susceptible to S-nitrosation. To
do this we developed a selective proteomic technique based
on the DIGE (difference in gel electrophoresis) method [8].
This approach, which we called SNO-DIGE (S-nitrosothiol
DIGE), allowed us to identify proteins containing thiols sensitive
to S-nitrosation selectively. SNO-DIGE is an extension of
a technique we previously developed, Redox-DIGE, which
we used to identify mitochondrial protein thiols sensitive
to ROS (reactive oxygen species) [9,10]. The SNO-DIGE
method provides signiﬁcant improvements in sensitivity over
previous proteomic screens for these low-abundance targets of
S-nitrosation. By making use of a highly selective reduction
of protein S-nitrosothiols [11] in a proteomic study we overcome
the insufﬁcient and non-speciﬁc reduction conditions used
in previous screens. Additionally, by incorporating controls
for biological variability into the experimental design, we
signiﬁcantly improved the statistical power of the method
[12,13]. Therefore using SNO-DIGE, we identiﬁed a number
of mitochondrial proteins that are novel targets of reversible
S-nitrosation. By investigating the functional consequences
of these modiﬁcations, we provide mechanistic insights into
mitochondrial protein S-nitrosation and its potential contribution
to mitochondrial physiology and pathology.
MATERIALS AND METHODS
Chemical syntheses
MitoSNO and MitoNAP (mito-N-acetylpenicillamine) were
synthesized as described previously [6]. Solutions were stored
in absolute ethanol at −80◦C. MitoSNO stability was assessed
prior to use from its absorbance at 340 nm.
Mitochondrial preparations and incubations
RHM (rat heart mitochondria) and RLM (rat liver mitochondria)
were prepared as described previously, by homogenization of
tissue in STE (250 mM sucrose, 5 mM Tris/HCl and 1 mM
EGTA, pH 7.4), supplemented with 0.1% fatty-acid-free BSA
for the heart, followed by differential centrifugation [14]. Protein
concentrations were measured by the biuret assay using BSA as
a standard [15].
Sample preparation for PrSNO (protein S-nitrosothiol) reduction
control experiments
RHM (2 mg protein) were incubated with 10 mM succinate
and 4 μg/ml rotenone to generate signiﬁcant mitochondrial
respiration, membrane potential and negligible superoxide
production, with or without 10 μM MitoSNO for 5 min at 37◦C
in 250 mM sucrose, 5 mM Hepes, 1 mM EGTA and 10 μM
neocuproine. Following incubation, 50 mM NEM (N-ethyl
maleimide) was added and the protein samples were pelleted.
Pellets were resuspended in an assay medium containing 10 mM
Hepes, 1 mM EGTA, 100 μM neocuproine and 50 mM NEM,
pH 7.4, and incubated for 5 min at 37◦C prior to the addition of
1% SDS and incubation for a further 5 min. NEM was removed
from the samples by passing them through three Micro Bio-Spin
6 chromatography columns (Bio-Rad), while maintaining a 1%
SDS concentration. Speciﬁc reduction and labelling of protein S-
nitrosothiols was achieved by addition of 1 mM ascorbate and
10 μMC u S O 4 in Chelex 100-treated PBS buffer, pH 7.5, in
the presence of 200 μM Cy3 (indocarbocyanine)-maleimide (GE
Healthcare). When UV photolysis was used to degrade PrSNOs
either before the addition of NEM or instead of copper(II) and
ascorbate reduction, samples were exposed to UV irradiation
at 355 nm at room temperature (23◦C )f o re i t h e r2o r5 m i n .
Incubation with the ﬂuorescent maleimide proceeded for 30 min
at 37◦C. The protein (20 μg) was then separated on SDS/PAGE
(12.5% gel). After electrophoresis, the gel image was acquired
with a Typhoon 9410 variable mode imager.
Sample preparation for SNO-DIGE and Redox-DIGE
RHM (2 mg of protein) were incubated as above, with or without
10 μM MitoSNO for 5 min at 37◦C. Following incubation,
50 mM NEM was added and the protein samples were pelleted.
Pellets were resuspended in an NEM-containing assay medium
as described above and incubated for 5 min at 37◦C prior to the
additionof1%SDSandincubationforafurther5 min.NEMwas
removed from the samples by passing them through three Micro
Bio-Spin 6 chromatography columns (Bio-Rad), maintaining
a1 % SDS concentration throughout. Speciﬁc reduction of
S-nitrosothiols in the samples was achieved by addition of 1 mM
ascorbate and 10 μMC u S O 4 in Chelex 100-treated PBS buffer in
t h ep r e s e n c eo f4 0μM CyDye
TM DIGE Fluor Cy
TM3 saturation
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dye (Cy3) or CyDye
TM DIGE Fluor Cy
TM5 saturation dye [Cy5
(indodicarbocyanine)] (GE Healthcare). After 30 min at 37◦C,
the excess CyDye
TM reactivity was quenched with 2.5 mM
DTT (dithiothreitol) and the samples were snap frozen on dry
ice prior to pooling and resolution by 2D (two-dimensional)
electrophoresis. Protein samples for Redox-DIGE were treated as
above,exceptthatforreductionsamplesweretreatedwith2.5 mM
DTT for 10 min at room temperature, instead of copper(II)
and ascorbate, prior to removal of DTT using two column
chromatography steps followed by reaction with Cy3 or Cy5
[9,10].
DIGE experimental design
To assess differences in ﬂuorescence using DIGE, sample
pooling on the basis of BVA (biological variance analysis) was
employed.EachDIGEexperimentusedthreebiologicalreplicates
from independently prepared mitochondria. One ﬂuorescent
component of each gel (in this case Cy3) comprised a pooled
standard of equal amounts of protein from each biological
replicate, and the Cy5 component of each gel was an individual
treatment (either control or MitoSNO treated) [13]. Each DIGE
analysis therefore consisted of six gels from three biological
replicates, where three compared the control condition to
the pooled standard and three compared the MitoSNO-treated
condition to the pooled standard.
Electrophoresis, gel imaging and analysis
Resolution of mitochondrial proteins by 2D gel electrophoresis
was carried out as described previously [9]. Gels were transferred
on to a Typhoon
TM 9410 imager (GE Healthcare). Cy3
ﬂuorescent images were obtained using a 532 nm laser and
a 580 nm emission ﬁlter (band pass 30 nm). Cy5 ﬂuorescent
images were obtained using a 633 nm laser and a 670 nm
emission ﬁlter (band pass 30 nm). All gels were scanned
at 100 μm pixel size, and the photomultiplier tube was set
to ensure a maximum pixel intensity within the range of
40000 and 80000. Analysis of the 2D ﬂuorescent images
was performed using the DeCyder
TM BVA module version
6.5(GEHealthcare),a2Dgelanalysissoftwarepackagedesigned
speciﬁcally for DIGE. The software was used following the
manufacturer’s recommendations. Brieﬂy, the estimated number
of spots was set to 2500 per gel, and each protein spot across
six gel images was matched automatically, then checked and
matched manually. Successfully matched spots were compared
acrossgroupsaccordingtoSA(standardizedabundance),wherea
sample spot ﬂuorescence volume (Cy5) is divided by the standard
spot volume (Cy3), normalized with ratiometric normalization
andtransformedwithalog10 function.ComparingSA,differences
acrossthetwogroupswereconsideredsigniﬁcantat>2,P<0.05.
Spot excision and MS
For MS of proteins from the DIGE analysis, 400 μg of ﬂuor-
escently tagged protein was separated by 2D gel electrophoresis
and the ﬂuorescent image was matched to the gels used for
image analysis. Then the gel was stained with Coomassie
Blue for spot excision. Coomassie Blue-stained images were
scanned and spot matched to overlaid ﬂuorescent images to
ensure accurate excision of proteins of interest. Protein spots
were digested by ‘in-gel’ cleavage [16] at 37◦C with 12.5 ng/ml
sequencing grade trypsin (Roche Applied Science) in 20 mM
Tris/HCl, pH 8.0, and 5 mM CaCl2. Peptides were extracted
from the gel with 4% ARISTAR-grade formic acid and 60%
acetonitrile solution. All digests were analysed in a model
4800 MALDI–TOF-TOF (matrix-assisted laser-desorption
ionization–time-of-ﬂight time-of-ﬂight) mass spectrometer
(Applied Biosystems) using α-cyano-hydroxy-trans-cinnamic
acid as the matrix. The instrument was calibrated with bovine
trypsin autolysis products (m/z values 2163.057 and 2273.160)
and a calcium-related matrix ion (m/z value 1060.048). Peptide
masses and peptide fragmentation data were searched against the
NCBI (National Center for Biotechnology Information) database
Rattusentrieswithapeptidetoleranceof+ −25p.p.m.,tandemMS
tolerance of + −0.8 Da and permitted missed cleavages of 1 [17].
Mitochondrial incubations for enzyme assays
RHM or RLM (2 mg of protein) were incubated with 10 mM
succinate and 4 μg/ml rotenone, with 10 μM MitoSNO, 10 μM
MitoNAP or no additions in a 120 mM KCl solution containing
1 mM EDTA, 1 mM DTPA (diethylenetriaminepenta-acetic acid)
and 10 μM neocuproine, pH 7.4, at 37◦C. At the indicated time
points, aliquots were removed and snap frozen on dry ice. To
reverse S-nitrosation, samples were incubated for 15 min at
room temperature in assay buffer containing 0.1% Triton X-
100 supplemented with 10 μMC u S O 4 and 1 mM ascorbate. To
reverse thiol oxidation, samples were incubated for 10 min at
room temperature in assay buffer containing 0.1% Triton X-100
supplemented with 1 mM DTT.
Mitochondrial enzyme activity assays
Mitochondrial aconitase activity was measured spectrophoto-
metrically by a coupled enzyme assay [18]. Protein (25 μg)
was added to 50 mM Tris/HCl, pH 7.4, 0.6 mM MnCl2,5m M
sodium citrate and 0.1% Triton X-100. After equilibration at
30◦C, 0.2 mM NADP
+ and 0.4 unit/ml isocitrate dehydrogenase
were added and the initial linear change in A340 was measured.
The activity of α-KGDH (α-ketoglutarate dehydrogenase) was
measuredspectrophotometrically[19].Protein(75 μg)wasadded
to 50 mM potassium phosphate buffer, pH 7.4, 0.2 mM EGTA,
0.2 mM thiamine pyrophosphate, 2 mM NAD
+,1m MM g C l 2,
0.4 mM ADP, 10 μM rotenone and 0.1% Triton X-100. After
equilibration at 30◦C, 0.12 mM CoA and 1 mM α-ketoglutarate
were added and the initial linear change in A340 was recorded.
Mitochondrial ALDH2 (aldehyde dehydrogenase) activity was
also measured spectrophotometrically [20]. For this, 500 μgo f
protein was added to 60 mM sodium phosphate buffer, pH 7.4,
1 mM EDTA, 1 mM NAD
+ and 1% Triton X-100 at 25◦C.
Then, 1 mM propionaldehyde was added and the initial linear
change in A340 was recorded.
Mouse heart I/R (ischaemia/reperfusion) experiments
M a l eC 5 7 B L / 6m i c e( ∼25 g) were purchased from the Jackson
Laboratory and handled in accordance with a protocol approved
by the procedures of the University of Rochester Committee
on Animal Research. All protocols were in accordance with
the NIH (National Institutes for Health) Guide for the care
and use of laboratory animals. All surgical procedures were
sterile and performed as described previously [21]. Brieﬂy,
analgesics (acetaminophen 0.75 mg/ml in drinking water) were
administered 24 h before, and during the perioperative period.
Followinganaesthesia(Avertin,2,2,2-tribromoethanol,0.5 mg/kg
intraperitoneally) mice were intubated and connected to a
rodent ventilator. A thoracotomy was performed and the LAD
(left anterior descending coronary artery) was then ligated and
occluded for 30 min. MitoSNO or MitoNAP (100 ng/kg) were
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dissolved in 0.9% NaCl saline (ﬁnal volume 50μl) and then
administered5 minpriortoreperfusionintotheLV(leftventricle)
using 30G×0.5 inch needle. Reperfusion was initiated by
removing the suture. The chest and skin were sutured closed,
the endotracheal tube removed and the animal returned to its
cage to recover. After 24 h, the animal was re-anaesthetized,
the LAD re-ligated, and Evans’ Blue dye (1.0%,w / v ,1 . 5m l )
was perfused via the LV. The heart was removed and cut
transversely into ﬁve sections, which were incubated in 1.0%
2,3,5-triphenyltetrazolium chloride at 37◦C for 10 min. The
AR (area at risk) and infarct zone were indicated by the
areas unstained with Evans’ Blue and TTC (triphenyltetrazolium
chloride) respectively [21]. Slices were scanned and infarct/AR
ratios determined with NIH ImageJ software.
RESULTS
The SNO-DIGE method
Previously published work suggested that a small number of
heart mitochondrial proteins were S-nitrosated by MitoSNO [6].
To identify these proteins, we developed a novel and sensitive
proteomictechnique,SNO-DIGE.Thedevelopmentofresolvable
ﬂuorescentDIGEdyesallowsforcomparisonofmultiplesamples
on a single 2D gel, greatly enhancing reproducibility and
conﬁdence in differences observed across the proteome [8].
Previously, we extended the basic DIGE method by developing
Redox-DIGE to identify mitochondrial thiol proteins that are
particularly sensitive to reversible oxidation during a redox
challenge[9,10].Todosowemadeuseofcysteine-reactiveDIGE
dyes[22]tolabeloxidizedproteinthiolsselectively.Inthepresent
studywehavefurtherextendedtheDIGEmethodologytoidentify
S-nitrosated proteins selectively (Figure 2). The procedure ﬁrst
relies on blocking exposed thiols with the alkylating agent NEM.
Critically, the S-nitrosated thiols are then selectively reduced by
copper(I), generated by treatment with ascorbate and copper(II)
sulfate [11] in the presence of ﬂuorescent Cy5 maleimide for the
S-nitrosatedandcontrolsamples,orinthepresenceofﬂuorescent
Cy3 maleimide for the standard samples. Thus the S-nitrosated
proteinsshouldcontainaCy5ﬂuorescenttag,whereasthecontrols
should not. This enables the spots containing the S-nitrosated
thiols to be selected and identiﬁed by peptide mass ﬁngerprinting
and tandem MS.
Previous work by our group and others has demonstrated
that copper (II) and ascorbate reduction of thiol proteins is
highly efﬁcient and speciﬁc for PrSNOs, leaving other reversible
thiol modiﬁcations intact [6,11]. To further support these
ﬁndings in the system employed in this study we used UV
photolysis, another means of degrading PrSNOs, to establish
the speciﬁcity of copper (II) and ascorbate reduction conditions
(see Supplementary Figure S1 at http://www.BiochemJ.org/
bj/430/bj4300049add.htm). Treatment of RHM with MitoSNO
followedbyNEMblockingoffreethiolsandreductionofPrSNOs
with copper(II) and ascorbate in the presence of a ﬂuorescent
maleimide dye resulted in ﬂuorescent tagging of a number of
mitochondrial thiol proteins (Supplementary Figure S1, lane
2). Subjecting samples to UV photolysis for 5 min following
MitoSNO treatment and prior to NEM blocking resulted in a
complete loss of the ﬂuorescent signal under the same reduction
conditions (Supplementary Figure S1, lane 4), suggesting that in
the presence of copper(II) and ascorbate, ﬂuorescent labelling
is exclusively of PrSNOs. In addition, degrading PrSNOs by
UV photolysis instead of copper(II) and ascorbate resulted in
labelling of virtually the same cohort of proteins (Supplementary
Figure S1, lanes 5 and 6 compared with lane 2). These ﬁndings
support previous work establishing the efﬁciency and speciﬁcity
of copper(II) and ascorbate reduction of PrSNOs and further
justify the use of these reduction conditions for use with SNO-
DIGE.
In carrying out SNO-DIGE, we made the ﬁrst use in a study of
this type of an experimental design based on BVA, which greatly
assists in the identiﬁcation of the small proportion of proteins
genuinely S-nitrosated by decreasing the impact of biological
variability across replicate experiments [12]. BVA makes use of
a pooled standard containing equal amounts of protein from three
biological replicates, against which each individual control or S-
nitrosated condition is compared. The advantage of this approach
is that it accounts for the effects of both biological and technical
variation, since the same pooled standard is present in each gel
and therefore can be used for inter-gel normalization [10,13,23].
Additionally, because the control and S-nitrosated conditions
under comparison both rely on proteins being tagged with the
same dye (Cy5 maleimide), dye-speciﬁc effects that can manifest
as false positives are eliminated [24].
TheSNO-DIGEmethodologyisdescribedindetailinFigure2.
Samples from the same source are either untreated (control
and standard, Figures 2A and 2B respectively) or treated with
MitoSNO (S-nitrosated, Figure 2C). NEM and SDS are then
added to the samples to block all exposed protein thiols.
Following the removal of NEM, ascorbate and copper(II) are
added to selectively reduce PrSNOs [11]. This PrSNO-speciﬁc
reduction proceeds in the presence of Cy5 maleimide (false
coloured red ﬂuorescence) for both control and treated samples
or in the presence of Cy3 maleimide (false coloured green
ﬂuorescence)forthestandardsample.ForeachDIGEexperiment,
samples are prepared from three independent biological samples,
following which all Cy3-labelled standard samples are pooled.
The normalized combined standard is then mixed individually
with each of the three Cy5 MitoSNO-treated samples and each
of the three Cy5 control samples. Six Cy3/Cy5 mixtures are then
resolved individually by 2D electrophoresis and scanned for Cy3
and Cy5 ﬂuorescence (Figures 2D and 2E). DeCyder
TM version
6.5BVAsoftware(GEHealthcare)wasusedtomatcheachprotein
spot and assess the ﬂuorescence differences across the six gels.
This enabled the differences between the Cy5 ﬂuorescence of
control and S-nitrosated samples to be compared, whereas the
pooled standard allowed for robust statistical analysis across gels.
As expected for SNO-DIGE analysis, most proteins were
unlabelled by the ﬂuorescent maleimide dyes in both control and
treated conditions, consistent with the majority of protein thiols
being in a reduced state (Figures 2D and 2E). A small number
of proteins appeared as intense yellow spots in both control
and S-nitrosated samples, indicating that these proteins were
equally labelled under both conditions. This was expected and
is due to occluded protein thiols, such as those involved in Fe-S
centres, that were unreactive with NEM but subsequently became
exposed during sample preparation [9]. We corroborated this by
identifying the four most prominent equally tagged proteins by
MS(seeSupplementaryTableS1athttp://www.BiochemJ.org/bj/
430/bj4300049add.htm). Those protein spots that were red in
the MitoSNO-treated gels (Figures 2E and 3A), but not in the
control gels (Figures 2D and 3A), were indicative of S-nitrosated
proteins. Thus we were able to resolve and distinguish a number
of S-nitrosated protein thiols sensitively using the SNO-DIGE
method.
Assessment of oxidized protein thiols by Redox-DIGE
A proportion of the S-nitrosation of mitochondrial proteins
by MitoSNO may be transient, relaxing to disulﬁde bond,
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Figure 2 SNO-DIGE experimental design
Protein from the same biological source is divided into three pools for a single replicate experiment: control (A), standard (B) and S-nitrosated (C). In control and standard samples, free protein
thiols are blocked with NEM in the presence of SDS, treated with ascorbate and CuSO4, and labelled with Cy5 and Cy3 maleimide (red and green respectively). In S-nitrosated samples treated with
MitoSNO (C), some protein thiols may become S-nitrosated and unreactive with NEM. S-nitrosated thiols can then be selectively reduced with ascorbate and CuSO4 and tagged with Cy5 maleimide
(red),whereasallotheroxidativemodiﬁcationsremainuntagged.TheCy3-labelledstandardsamplefromasinglereplicateispooledwiththestandardsamplefromtwoindependentpreparationsand
combinedindividuallywiththecontrolandtreatedCy5samplesofeveryreplicatesample(threecontrol,threetreated;sixintotal).Combinedsamplesareresolvedby2Delectrophoresisonthesame
gel and scanned for red and green ﬂuorescence. Protein spots that appear red on the superimposed image of the treated gels (E), but not the control gels (D), have undergone MitoSNO-mediated
S-nitrosation. Spots that appear yellow in both gels when the Cy3 and Cy5 false colour images are overlaid are persistently occluded thiols that exist in equal proportion in all conditions. Pr-S-S,
intramolecular protein disulﬁdes; Pr-S-SG, protein mixed disulﬁdes with glutathione; Pr-SOH, protein sulfenic acids.
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Figure 3 Effects of MitoSNO on mitochondrial protein thiols determined by SNO-DIGE and Redox-DIGE
Mitochondria were untreated or incubated with MitoSNO, and labelled with Cy5 maleimide (red) following either S-nitrosothiol speciﬁc reduction (A, SNO-DIGE) or non-speciﬁc reduction
(B, Redox-DIGE). Cy5-labelled samples were combined separately with a Cy3-labelled sample (green) pooled from all replicate experiments and resolved on the same 2D gel. The superimposed
ﬂuorescent scans of representative gels from each triplicate experimental condition are shown. Gels used for identiﬁcation of proteins of interest by MS were subsequently stained with Coomassie
Blue (C).
glutathionylation or sulfenic acid modiﬁcations [2,25–27]. To
distinguish those proteins that are persistently S-nitrosated from
those that go on to form other thiol modiﬁcations, or which are
directly oxidized in the S-nitrosating conditions, we conducted a
Redox-DIGE analysis in parallel on these samples. Redox-DIGE
identiﬁes proteins that undergo all reversible thiol modiﬁcations,
including S-nitrosation [9], therefore all spots that are positive
for modiﬁcation by Redox-DIGE should include those identiﬁed
by SNO-DIGE and perhaps additional candidates. The parallel
analysis of samples by Redox-DIGE revealed a number of thiol
modiﬁcations induced by MitoSNO (Figure 3B).
Comparison of S-nitrosated mitochondrial protein thiols by
SNO-DIGE and oxidized protein thiols by Redox-DIGE
Both SNO-DIGE and Redox-DIGE analyses showed that a
number of proteins were S-nitrosated and/or had thiols oxidized
onexposuretoMitoSNOwhencomparedwithcontrolincubations
(Figures 3A and 3B). To determine whether an observed
difference in ﬂuorescence between the control and treated groups
was due to a statistically signiﬁcant alteration to the protein thiols
of interest, we employed a threshold requiring a ﬂuorescence
ratio difference >2( P<0.05). According to these criteria, 18
spots corresponding to distinct proteins were found to show
signiﬁcantdifferencesaccordingtoSNO-DIGEanalysis,whereas
23 such spots were found according to Redox-DIGE analysis. As
expected, there was considerable overlap between the identities
of the proteins corresponding to these spots. Importantly, all but
three proteins showing changes with SNO-DIGE also did so
with Redox-DIGE. No false positives were observed (in which
ﬂuorescent ratios were signiﬁcantly higher in control gels versus
S-nitrosated samples), suggesting that the selection criteria used
were sufﬁciently stringent.
Identiﬁcation of S-nitrosated and oxidatively modiﬁed
mitochondrial thiol proteins
The DIGE analyses enabled us to locate mitochondrial protein
spots on a 2D gel that underwent a statistically signiﬁcant
change in Cy5 ﬂuorescence intensity following treatment with
MitoSNO and PrSNO speciﬁc reduction of thiols (SNO-DIGE),
or reduction of all reversible thiol modiﬁcations (Redox-DIGE).
To identify these proteins we excised gel spots from Coomassie
Blue-stained gels (Figure 3C) matched to the Cy ﬂuorescent
images, and identiﬁed the proteins by MALDI–TOF-TOF MS.
A Coomassie Blue-stained gel indicating the locations of the
selected protein spots is shown in Supplementary Figure S2
(at http://www.BiochemJ.org/bj/430/bj4300049add.htm), and all
proteins that could be unambiguously identiﬁed by these means
are listed in Table 1. Of the spots corresponding to single proteins
classiﬁed as signiﬁcant from the analyses, 13 of 18 from the
SNO-DIGE analysis and 16 of 23 from the Redox-DIGE analysis
wereidentiﬁed.Table1(A)liststhe13proteinsidentiﬁedasbeing
S-nitrosated from the SNO-DIGE analysis, whereas Table 1(B)
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Table 1 Mitochondrial proteins containing thiols sensitive to modiﬁcation by MitoSNO as identiﬁed by SNO-DIGE or Redox-DIGE
Thiol proteins sensitive to S-nitrosation (A) and oxidative modiﬁcation (B) due to MitoSNO treatment are listed. The predicted molecular mass (MM) and isoelectric points (pI, in parentheses) of
mature proteins are shown and are found in all cases to match closely to those observed on the gels. MASCOT PMF scores>59 (Rattus entries) for the peptide ion masses searched are signiﬁcant
(P <0.05). For the tandem MS fragment ion masses, the number of signiﬁcant (P <0.05) MASCOT peptides are listed. Mean ﬂuorescence ratios between the MitoSNO-treated and control values
are listed for proteins showing a signiﬁcant difference in either SNO-DIGE or Redox-DIGE analyses (difference>2), as well as the associated P-values (one-way ANOVA; **P <0.01; *P <0.05).
The number of cysteine residues contained in each mature protein of interest is provided, as well as a summary of the novelty of candidate identiﬁcation. IPC, ischemic preconditioning.
Candidate MS data DIGE analysis summary Literature Summary
Number of
peptide SNO analysis Redox analysis Identiﬁed as a target
NCBInr ‘gI’ % Sequence MASCOT sequences ﬂuorescence ﬂuorescence Cysteine for S-nitrosation or
accession Protein name MM (pI) coverage PMF score (MS/MS) ratio ratio residues thiol oxidation
(A)
TCA cycle
40538860 Mitochondrial aconitase 82462 (7.15) 37 463 5 3.18** 2.58** 12 [7] (IPC/GSNO)
62945278 α-KGDH 111686 (6.00) 12 173 3 6.06** 2.31** 19 [7] (IPC)
18426858 Succinate dehydrogenase, subunit A ﬂavoprotein 68004 (6.17) 29 478 6 2.30* 3.00 18 The present study
Fatty acid catabolism
6978435 Very long chain acyl-CoA dehydrogenase 66382 (8.10) 17 110 2 2.62** 5.15** 6 The present study
11968090 Short chain acyl-CoA dehydrogenase 42187 (6.38) 15 73 1 2.47* 2.00* 5 The present study
2392291 Enoyl-CoA hydratase 28287 (6.41) 36 160 2 2.29** 1.95 5 The present study
52138635 Electron-transferring ﬂavoprotein dehydrogenase 64483 (6.47) 21 261 3 3.40** 2.68** 11 The present study
1850592 Carnitine palmitoyl transferase 2 71262 (6.43) 49 520 4 2.81** 2.74** 9 The present study
Other metabolic enzymes
51948476 Complex III, core protein 1 49380 (5.22) 10 165 2 2.17** 2.13 9 The present study
14192933 ALDH2 (mitochondrial) 54368 (5.69) 9 180 3 2.20** 3.98 9 [20] (GSNO/SNAP)
Other
62079055 Isocitrate dehydrogenase (NADP+) 46640 (8.49) 20 94 2 2.06** 2.66** 11 The present study
25742763 78kDa Glucose regulated protein 72302 (5.07) 19 415 4 7.00** Not focused 3 The present study
3915779 Myosin heavy chain 6 223488 (5.68) 15 432 6 2.95* 2.24** 14 [7] (IPC)
(B)
57527204 Electron-transferring ﬂavoprotein α polypeptide 34929 (8.62) 31 437 4 1.26 4.04* 6 [7] (GSNO)
6978431 Long chain acyl-CoA dehydrogenase 44672 (6.26) 33 272 4 0.88 2.00** 6 The present study
20304123 3-Mercaptopyruvate sulfurtransferase 32809 (5.88) 28 277 4 1.25 2.83** 5 The present study
149036390 Mitoﬁlin 83484 (6.18) 27 319 3 0.86 7.84* 7 The present study
lists the four additional proteins found to be oxidatively modiﬁed
by the Redox-DIGE analysis following MitoSNO-treatment,
but which were not detected by SNO-DIGE. One observed
discrepancy between the analyses is due to the 78 kDa glucose-
regulatedprotein,whichwasdetectedbytheSNO-DIGEanalysis,
but was poorly focused on the 2D gels during the Redox-DIGE
analysis. Consequently, a reliable ﬂuorescence ratio was not
obtained (Table 1). Additionally, a small number of candidates
from the SNO-DIGE analysis fell just below the threshold of
signiﬁcance (ﬂuorescence ratio >2, P<.05) in the Redox-DIGE
analysis(Table1).ThemeanﬂuorescenceratiobetweenMitoSNO
treated and control spots are included from both analyses, the
number of cysteine residues contained in each identiﬁed protein,
and a summary of the MS data used to identify the protein are
also provided in Table 1. Additionally, we indicated whether
the candidate proteins have previously been reliably reported
as targets for S-nitrosation. The MS data used to identify the
proteins are more fully described in Supplementary Table S2 (at
http://www.BiochemJ.org/bj/430/bj4300049add.htm). As shown
inTable1(A),theﬂuorescenceratiosobtainedfortheS-nitrosated
proteins by the SNO-DIGE and Redox-DIGE analyses for most
proteins are very similar. This suggests that for these proteins,
the change in thiol redox state indicated by Redox-DIGE was due
largely to S-nitrosation and that other thiol redox modiﬁcations
did not occur to a signiﬁcant extent. One exception is the very
long chain acyl-CoA dehydrogenase, which had a nearly 2-fold
higher ﬂuorescence ratio by Redox-DIGE analysis over SNO-
DIGE, suggesting that a signiﬁcant proportion of this enzyme
was both S-nitrosated and oxidatively modiﬁed. Interestingly,
although nearly all of the S-nitrosated proteins identiﬁed are
involved in mitochondrial metabolism, Redox-DIGE analysis
identiﬁed mitoﬁlin, a mitochondrial membrane protein that is
thought to be involved in modulating cristae morphology [28], as
a target for thiol oxidation due to MitoSNO action.
It is noteworthy that nearly all of the mitochondrial proteins
identiﬁed by SNO-DIGE and by Redox-DIGE are found in
the mitochondrial matrix compartment, with two exceptions. The
78 kDa glucose-regulated protein is generally regarded as an
endoplasmic reticulum protein, however, it has been reported to
bepresentinmitochondrialmatrix[29].Also,myosinheavychain
VI has not been reported as being associated with mitochondria
and is involved with intracellular vesicle trafﬁcking [30].
S-nitrosation of metabolic enzymes by MitoSNO results in
reversible inhibition
SNO-DIGE analysis identiﬁed a small number of heart
mitochondrial proteins that were persistently S-nitrosated by
MitoSNO. Surprisingly, the majority of novel targets identiﬁed
are enzymes central to mitochondrial metabolism, so these
proteins are all candidates for the biological consequences of
mitochondrial S-nitrosation through regulation of mitochondrial
function. However, for this to be the case S-nitrosation must
affect enzyme activity. To determine if this occurred, we
selected three candidate enzymes from the proteins identiﬁed
as targets of S-nitrosation: mitochondrial aconitase, α-KGDH
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Figure 4 Reversible inhibition of enzyme activity due to S-nitrosation by
MitoSNO
Metabolic enzymes found to be S-nitrosated from the SNO-DIGE analysis were measured for
changes in activity due to MitoSNO action. (A) Mitochondrial aconitase activity was found
to decrease, beginning 5 min following MitoSNO treatment and showing signiﬁcant inhibition
beyond 10min when compared with the vehicle control. Addition of copper(II) and ascorbate to
selectivelyreducePrSNOsfollowingtreatmentwithMitoSNOcompletelyreversedtheinhibitory
effect.(B)α-KGDHactivitywasalsoinhibitedbyMitoSNOaction,causingsigniﬁcantinhibition
20minfollowingMitoSNOaddition.TheinhibitoryeffectofMitoSNOwasreversedbycopper(II)
and ascorbate. (C) MitoSNO signiﬁcantly inhibited mitochondrial ALDH2 5 min following its
addition and onwards, and the inhibitory effect was completely reversed by copper(II) and
ascorbate. Error bars show means+ −S.E.M.; *P <0.05; **P <0.01 by Student’s t test.
and mitochondrial ALDH2. Both aconitase and α-KGDH are
citric acid cycle enzymes and central to mitochondrial energetics,
whereas ALDH2 is a key enzyme in the NAD
+-dependent
detoxiﬁcation of aldehydes [31].
The activities of all three enzymes were signiﬁcantly and
progressively inhibited by MitoSNO (Figure 4), whereas the
control compoundMitoNAP, which lacksan S-nitrosating moiety
but is identical to MitoSNO in every other respect, had no
effect(seeSupplementaryFigureS3athttp://www.BiochemJ.org/
bj/430/bj4300049add.htm). Subsequent removal of NO from the
PrSNO by incubation of S-nitrosated mitochondrial extracts with
DTT restored activity for all three enzymes (Supplementary
Figure S3). However, although DTT will reverse S-nitrosation,
it is not selective and will reverse many other thiol modiﬁcations.
Therefore we treated S-nitrosated mitochondrial samples with
copper(II) and ascorbate to selectively degrade S-nitrosothiols
and found that this treatment completely restored the activity
of all three enzymes (Figure 4). Control experiments showed
that inhibition of the enzymes by the thiol oxidant diamide was
not reversed by copper(II) and ascorbate treatment (results not
shown), corroborating our previous results showing that this
reduction is highly selective for PrSNOs [6]. These ﬁndings not
only demonstrate the mechanistic consequences of S-nitrosation
for these candidate proteins, but establish the full reversibility of
the modiﬁcation using the same selective reduction by copper(II)
and ascorbate employed for the SNO-DIGE method.
Figure 5 MitoSNO is protective against cardiac I/R injury in vivo
Cardiac I/R injury was established in a mouse in vivo model by LAD occlusion for 30min,
followed by reperfusion and 24 h recovery, at which point the area of infarcted heart tissue
was determined. MitoSNO or MitoNAP (100ng/kg), or vehicle carrier, was injected directly
into the left ventricle after 25min ischaemia, 5 min prior to reperfusion. (A) Two representative
formalin-ﬁxed heart cross-sectional images at the center of ventricles for each condition. Dark
blue,non-riskzone;palewhite,necroticinfarctedtissue;deepred,livetissue.(B)Quantiﬁcation
of the infarct size as a percentage of the AR. Data from individual experiments are shown on
the left and the means+ −S.E.M. is shown on the right. , vehicle carrier; , MitoSNO; ,
MitoNAP. (C) Quantiﬁcation of the proportion of entire heart tissue identiﬁed as AR in the same
groups. n=7–8 per group; *P <0.05 by between groups ANOVA.
MitoSNO protects against cardiac I/R injury in vivo
SincemitochondrialS-nitrosationcorrelateswithprotectioninI/R
injury, we examined whether MitoSNO would be protective. To
doso,wemadeuseofthewell-establishedmurinemodelofinvivo
I/R injury by subjecting mice to occlusion of the LAD for 30 min
followed by reperfusion and recovery over 24 h [21]. Following
the recovery period, analysis of the heart showed signiﬁcant
damage, as indicated by the area of infarcted tissue (Figure 5A,
white tissue), and by comparison of the infarcted zone to the AR
(Figures 5B and 5C). In contrast, injection of MitoSNO into the
left ventricle 5 min prior to reperfusion signiﬁcantly decreased
heart damage (Figures 5A and 5B). Control injections with
MitoNAP, the MitoSNO precursor that lacks the S-nitrosothiol,
were not protective (Figure 5).
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DISCUSSION
Protein S-nitrosation has emerged as a signiﬁcant component
of NO action within mitochondria [1,2,4], although the breadth
and consequences of mitochondrial protein S-nitrosation are
not yet fully understood. To help address this, we set out to
identify mitochondrial thiol proteins that were susceptible to S-
nitrosation. To do so we used MitoSNO, a mitochondria-targeted
S-nitrosothiol [6], because the cohort of mitochondrial proteins
that are S-nitrosated by MitoSNO is likely to be similar to
thoseproteinsthatareS-nitrosatedunderphysiologicalconditions
[6].
To identify these S-nitrosated mitochondrial thiol proteins, we
developed a sensitive and selective proteomic technique, SNO-
DIGE (Figure 2). By making use of the highly speciﬁc reduction
of protein S-nitrosothiols by copper(II) and ascorbate, DIGE to
resolve the mitochondrial proteome, and an experimental design
incorporating sample pooling based on BVA, we were able to
obtainhighlyreproducibleresultsandavoidvariabilityassociated
with comparing gel pairs and replicates. A central advantage
of the DIGE approach is its reliance on sensitive ﬂuorescence
detection, which allows for the identiﬁcation of low-abundance
proteins [9,32]. The SNO-DIGE method further extends this
sensitivity to facilitate the robust detection of the low-abundance
targets for S-nitrosation. Previously, studies using DIGE methods
to identify PrSNOs have relied on the comparison of protein
from different biological sources within one gel [7,33], so that
control protein was derived from a different specimen from
treated protein. This design does not account for the effect of
biological variability due to differences in individual protein
abundance between replicates as opposed to differences due to
S-nitrosation, thereby signiﬁcantly increasing signal noise, and
the chances of false negative and false positive results [13,34].
In the present study we compared changes in S-nitrosation from
the same biological source, effectively controlling for biological
variability. In addition, we made use of a pooled standard in
each gel comprising equal amounts of protein from all biological
replicates.Thisapproachsigniﬁcantlyreducesbothbiologicaland
technical variability, increasing the statistical power of the
analysis [13,34]. It also controls for dye-speciﬁc effects and
overcomes the difﬁculty of matching gel pairs to obtain reliable
and semi-quantitative results [8,35,36]. Finally, the SNO-DIGE
method is the ﬁrst to make use of the copper(I)-dependent
PrSNO reduction in a proteomic screen [11], which has been
shown by our group and others to be a highly speciﬁc means of
reducing PrSNOs and leaving other reversible thiol modiﬁcations
unaffected (Supplementary Figure S2) [6,11]. Previous studies
have either relied on ascorbate reduction in the presence of
copper chelators [7] or on higher concentrations (5–10 mM)
ofascorbate[33,37],whichhavebeenshowntobeinsufﬁcientand
non-speciﬁc methods for PrSNO reduction respectively [11,38–
41]. In summary, the SNO-DIGE method provides a signiﬁcant
improvement in speciﬁcity, sensitivity and reproducibility for
proteomic screens of PrSNOs, which is essential for the robust
identiﬁcation of such a scarce modiﬁcation, and can be applied to
the identiﬁcation of S-nitrosated proteins in many other systems.
A potential limitation of the SNO-DIGE approach is the
requirement for 2D electrophoresis, which under-represents
hydrophobic membrane proteins [9]. It is also possible that the
S-nitrosation of proteins containing a number of occluded thiols,
such as iron-sulfur proteins, may be difﬁcult to detect by this
procedure. This arises from the fact that initially unreactive
thiols may become exposed and then show strong labelling
by both the Cy3 and Cy5 dye, resulting in spots with equally
intense ﬂuorescence in both channels (appearing yellow) on the
gels that may mask changes occurring on other thiols on the
same or on a co-localized protein. These are likely to be the
reasons why complex I, which is known to be S-nitrosated by
MitoSNO [6], was not detected by this screen as its subunits
are hydrophobic or contain many iron-sulfur centres. However,
the principles underlying the SNO-DIGE methodology are easily
adaptabletoothergelsystemsandshouldenabletheserestrictions
to be overcome ([6] and E. Chouchani and M. P. Murphy,
unpublished work). Finally, although SNO-DIGE allows for
robust protein identiﬁcation, reliable assessment of the modiﬁed
cysteine residue(s) is not possible. Knowledge of the cysteine
residue modiﬁed in candidate proteins and the extent of their
S-nitrosation are vital for understanding the physiological and
pathological consequences of mitochondrial S-nitrosation. To do
this, further studies are underway using orthogonal approaches to
determinetheresiduesaffectedinthecandidateproteinsidentiﬁed
by SNO-DIGE and to quantify their extent of S-nitrosation.
Application of the SNO-DIGE method to heart mitochondria
allowed us to identify a number of novel proteins that contained
thiolssensitivetopersistentS-nitrosation,aswellastocorroborate
targets that have been identiﬁed previously (Table 1). A parallel
Redox-DIGE analysis determined that the majority of thiol
modiﬁcations due to MitoSNO action were indeed persistent
S-nitrosation. Only three proteins modiﬁed in the SNO-DIGE
analysis were not also found in the Redox-DIGE analysis. Those
not found were either just below the threshold of signiﬁcance
or were poorly focused in the Redox-DIGE gels, resulting in
the inability to match spots across gels and obtain statistical
signiﬁcance. These ﬁndings also indicated that there was a
small pool of thiol proteins that underwent thiol oxidation but
were not S-nitrosated under these conditions. This is likely to
occur due to transient S-nitrosation of mitochondrial proteins
followed by subsequent relaxation of the S-nitrosothiol to other
thiol redox modiﬁcations [2]. Alternatively, these proteins may
become oxidized as a consequence of the effect of S-nitrosation
of other mitochondrial proteins. These complementary ﬁndings
from the two DIGE analyses exemplify the reproducibility of the
twotechniques,whereasthenumberofnewlyidentiﬁedcandidate
proteinsforS-nitrosationdemonstratesthesigniﬁcantlyimproved
speciﬁcity and sensitivity of the SNO-DIGE methodology.
The cohort of proteins modiﬁed by MitoSNO contrasts with
those affected by incubation of mitochondria with the non-
targetedS-nitrosatingagentSNAP[9],whichwerepredominantly
outer membrane proteins or contaminating cytosolic proteins.
This discrepancy is probably due to the extensive and selective
uptake of MitoSNO into mitochondria driven by membrane
potential and leading to the selective S-nitrosation of matrix
proteins [6]. Interestingly, the majority of proteins identiﬁed were
metabolic enzymes responsible for both carbohydrate and fatty
acid oxidation. Five enzymes involved in the oxidation of fatty
acids were identiﬁed as targets for S-nitrosation. These include
the very-long-chain acyl-CoA dehydrogenase, short-chain acyl-
CoA dehydrogenase and enoyl-CoA hydratase, which catalyse
the initial oxidation step and subsequent hydration of unsaturated
carbons in the β-oxidation pathway of very-long-chain and
short-chain fatty acids [42]. Also identiﬁed were carnitine
palmitoyl transferase 2 and the electron-transferring ﬂavoprotein
dehydrogenase, which are responsible for the initiation of β-
oxidation and ﬁnal supply of electrons from fatty acid catabolism
to the mitochondrial Q-pool [43] respectively. Interestingly, three
citric acid cycle enzymes were also identiﬁed by SNO-DIGE:
aconitase, which catalyses the initial isomerization of citrate;
α-KGDH, which catalyses the NADH-coupled oxidation of
α-ketoglutarate; and succinate dehydrogenase, which oxidizes
succinate to reduce the Q-pool. These ﬁndings indicate that the
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S-nitrosation of mitochondrial protein thiols targets a number of
enzymes central to mitochondrial metabolism, speciﬁcally those
supplying electrons to the respiratory chain from the breakdown
of both carbohydrates and fatty acids.
In addition to those proteins involved in metabolism, mitoﬁlin
was identiﬁed as containing redox-sensitive thiols. Although the
function of mitoﬁlin has not been fully elucidated, it has been
suggested that it modulates mitochondrial cristae organization
[28], and participates in protein import into the matrix [44].
Although several studies highlight the detrimental effects of
mitoﬁlin depletion, this is the ﬁrst indication that it may be
responsivetoredoxregulationandmaysuggestaroleformitoﬁlin
in the response of mitochondrial morphology to oxidative stress
and redox signalling.
To determine the functional consequences of S-nitrosation, its
impact was assessed on the activity of three of the enzymes
indentiﬁed in the SNO-DIGE screen: mitochondrial aconitase,
α-KGDH and ALDH2. S-nitrosation correlated with inhibition
of all three enzymes, and these decreases in activity were
reversed by reducing S-nitrosothiols with DTT (Supplementary
Figure S3) and by treatment with copper(II) and ascorbate
(Figure 4), which is selective for the reduction of S-nitrosothiols.
These results were signiﬁcant as they provided an orthogonal
validation for the proteomic screen and showed that the proteins
identiﬁedbySNO-DIGEwereindeedsusceptibletoS-nitrosation.
In addition, these ﬁndings indicated that the S-nitrosation by
MitoSNO had functional consequences for these enzymes, that
this decrease in activity was due to S-nitrosation, and that
inhibition was readily reversible by speciﬁc reduction of the S-
nitrosothiol. This is consistent with the reversible S-nitrosation
of mitochondrial proteins being involved in the regulation of
mitochondrial function. The reversal of inhibition by copper(II)
and ascorbate also indicates that the treatment used for PrSNO
reduction in SNO-DIGE is mild and has minimal damaging side
effects on proteins.
Exploring the functional effects of S-nitrosation of central
mitochondrial enzymes provided insights regarding their
interaction with NO. Mitochondrial aconitase is known to be
inactivated by superoxide and peroxynitrite, whereas inhibition
due to NO is thought to occur only at high non-physiological
concentrations [18]. In contrast, here we have demonstrated
that aconitase can be readily S-nitrosated by low concentrations
of MitoSNO, resulting in moderate inhibition of enzyme
activity, which is reversible upon reduction of the S-nitrosothiol
(Figure 4A). This is likely to be due to the reversible S-
nitrosation of a cysteine residue on aconitase; however, we
cannot exclude the possibility of a contribution from a putative
reversible [4Fe-4S]-NO adduct of the active site iron centre
[45]. Interestingly, the NO-donor GSNO (S-nitrosoglutathione)
has been shown to irreversibly inactivate aconitase, suggesting
either discrepant mechanisms of inactivation exist or perhaps
that irreversible inactivation occurs following only prolonged
exposure to very high concentrations of NO donors [45]. α-
KGDH has been suggested as a target of S-nitrosation previously,
but not unequivocally identiﬁed as such [7]. Its activity has been
shown to increase following addition of very high concentrations
of GSNO, but this change was not tested for reversibility [7].
Our SNO-DIGE analysis corroborated that α-KGDH can be S-
nitrosated, but under our S-nitrosating conditions there was a
moderatedecreaseinactivitythatwasreversedbyreductionofthe
S-nitrosothiol (Figure 4B). The S-nitrosation of ALDH2 by high
(0.5 and 1.0 mM) concentrations of GSNO and SNAP inhibits
its activity in rat hepatoma cells [20]. We demonstrated a similar
moderate inhibition by MitoSNO-induced S-nitrosation that was
completely reversible (Figure 4C).
The ﬁndings that S-nitrosation inhibits a number of mitochon-
drial metabolic enzymes extends previous work showing that S-
nitrosationofcomplexIdecreasesitsactivity[2,6].Theinhibition
ofcomplexIhasbeensuggestedtobeprotectiveduringI/Rinjury
by preventing mitochondrial ROS production and calcium over-
loading [2,6,46,47]. It may be that the mild, reversible inhibition
byS-nitrosationofcitricacidcycleandβ-oxidationenzymesalso
contributes to this process by preventing the build up of NADH
and a reduced Q-pool during I/R which may produce a burst of
damaging free radicals during reperfusion [48]. Additionally, it
hasbeensuggestedthattheS-nitrosationofthiolproteinsmayalso
act to prevent their irreversible inactivation by oxidative damage
[49]. Consistent with these ﬁndings, in a preliminary experiment
we found that administration of just 100 ng/kg of MitoSNO
was protective in an in vivo model of cardiac I/R injury. Thus
MitoSNO is signiﬁcantly more potent that other cardioprotective
NO donors when administered just prior to the reperfusion
phase of I/R injury (Figure 5) [7,21,50]. This is consistent with
rapid uptake of MitoSNO into mitochondria and S-nitrosation of
mitochondrialproteins[6].ThusMitoSNOmayprotectduringI/R
injury partly by inhibiting central metabolic enzymes, decreasing
mitochondrialoxidativedamagethroughlimitingsubstratesupply
and by protecting protein thiols from irreversible oxidation.
However, future work will be required to establish the role
of mitochondrial protein S-nitrosation in vivo and its potential
contribution to the protective effect observed in I/R injury.
In summary, we have developed a proteomic method, SNO-
DIGE, for the highly selective identiﬁcation of low-abundance
S-nitrosated protein thiols. We have used this method to
identify a number of novel mitochondrial targets of S-nitrosation.
The majority of these targets were enzymes responsible for
carbohydrate and fatty acid catabolism, and we demonstrated
that for three of these targets S-nitrosation reversibly inhibited
enzymatic activity. These ﬁndings are consistent with the S-
nitrosation of mitochondrial proteins regulating mitochondrial
energetics and function, providing insight into the physiological
and pathological roles of NO.
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Identiﬁcation of S-nitrosated mitochondrial proteins by S-nitrosothiol
difference in gel electrophoresis (SNO-DIGE): implications for the
regulation of mitochondrial function by reversible S-nitrosation
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Table S1 Identity of thiol proteins containing occluded thiols determined by SNO-DIGE and Redox-DIGE
Protein spots were excised from 2D gels, digested with trypsin by the ‘in-gel’ cleavage method and analysed by MALDI–TOF-TOF MS. For peptide ion masses searched (MS data), MASCOT
scores>59 (Rattus database) are signiﬁcant (P<0.05). For the tandem MS fragment masses (supporting tandem MS data), the values required for signiﬁcance (P<0.05) are reported in brackets
after the MASCOT ion score. Amino acids are abbreviated using standard one character symbols. Residue numbers correspond to the complete protein sequences found in the NCBI database. The
established nature of the occluded thiols for each candidate is included. MM, molecular mass.
Candidate MS data Supporting tandem MS data
Peptide matches MASCOT
NCBInr ‘gI’ % Sequence at 25 p.p.m./ MASCOT Mass (MH+) score
accession Protein name MM (pI) coverage supplied score Observed calculated Residues Sequence (P <0.05) Thiols
58865384 Complex I 49 kDa
subunit
49243 (5.95) 29 18 of 45 355 934.5278 934.5363 172–179 VLFGEITR 50 (38) Fe-S
1047.6228 1047.6315 158–166 LLNIQPPPR 43 (38)
2228.1182 2228.0512 305–323 TQPYDVYDQVEFDVPIGSR 111 (38)
51092268 Complex I 24 kDa
subuit
23933 (5.07) 32 11 of 18 320 1244.6405 1244.6375 199–208 DIEEIIDELR 64 (29) Fe-S
1336.7994 1336.7953 75–87 AAAVLPVLDLAQR 63 (29)
2398.0083 2398.0112 42–61 DTPENNPDTPFDFTPENYER 126 (29)
125313 Mitochondrial
creatine kinase
43144 (7.78) 30 14 of 45 348 1390.6908 1390.7008 47–58 LFPPSADYPDLR 57 (38) Exposed
2109.0044 2109.0101 285–305 GTGGVDTAAVADVYDISNIDR 121 (38)
1673.8197 1673.8288 258–270 TFLIWINEEDHTR 59 (38)
40786469 Dihydrolipoamide
dehydrogenase
50089 (6.51) 20 12 of 41 217 1127.6536 1127.6578 133–143 ALTGGIAHLFK 42 (37) Exposed
1737.8724 1737.8825 90–104 ALLNNSHYYHLAHGK 73 (37)
2169.1428 2169.1556 316–334 RPFTQNLGLEELGIELDPK 41 (37)
1 To whom correspondence should be addressed (email mpm@mrc-mbu.cam.ac.uk).
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Table S2 Identity of proteins containing thiols S-nitrosated and/or oxidized by MitoSNO
Protein spots were excised from 2D gels, digested with trypsin by the ‘in-gel’ cleavage method and analysed by MALDI–TOF-TOF MS. For peptide masses (MS data), MASCOT scores >59 (Rattus database) are signiﬁcant (P <0.05). For the MS/MS fragment
masses(supportingtandemMSdata)thevaluesrequiredforsigniﬁcance(P <0.05)arereportedinbracketsaftertheMASCOTionscore.Aminoacidsareabbreviatedusingstandardonecharactersymbols,underlinesindicateoxidizedresidues.Residuenumbers
correspond to the complete prtoein sequences found in the NCBI database. MM, molecular mass.
Candidate MS data Supporting tandem MS data
NCBInr ‘gI’ % Sequence Peptide matches MASCOT Mass (MH+) MASCOT
accession Protein name MM (pI) coverage at 25 p.p.m./supplied PMF score Observed calculated Residues Sequence score (P <0.05)
40538860 Mitochondrial aconitase 82462 (7.15) 38 28 of 42 463 1463.7299 1463.7489 412–424 SQFTITPGSEQIR 43 (38)
1500.7908 1500.7693 522–534 FKLEAPDADELPR 67 (33)
1601.8160 1601.7918 634–648 NAVTQEFGPVPDTAR 39 (33)
1667.7926 1667.7660 657–671 WVVIGDENYGEGSSR 85 (33)
1868.9332 1868.9137 69–84 IVYGHLDDPANQEIER 33 (33)
62945278 α-KGDH 111686 (6.00) 12 17 of 30 173 1402.6545 1402.6750 962–972 NQGYYDYVKPR 52 (29)
2002.0024 2001.9988 82–101 NTNAGAPPGTAYQSPLSLSR 65 (32)
929.4537 928.4654 908–914 VYYDLTR 25 (24)
25742763 78 kDa Glucose-regulated protein 72302 (5.07) 19 24 of 28 415 1566.7546 1566.7799 62–75 ITPSYVAFTPEGER 39 (33)
1887.9493 1887.9712 166–182 VTHAVVTVPAYFNDAQR 49 (33)
1933.9932 1934.0131 476–493 DNHLLGTFDLTGIPPAPR 75 (33)
2148.9915 2148.9972 308–325 IEIESFFEGEDFSETLTR 52 (33)
6978435 Very long chain acyl-CoA dehydrogenase 66382 (8.10) 17 9 of 27 103 1316.7367 1316.7321 557–567 GIVNEQFLLQR 47 (34)
2577.3167 2577.3306 138–162 ELGAFGLQVPSELGGLGLSNTQYAR 20 (34)
52138635 Electron-transferring ﬂavoprotein dehydrogenase 64483 (6.47) 21 15 of 31 261 1291.6418 1291.6277 548–558 NLSIYDGPEQR 37 (38)
1428.7814 1428.7706 344–356 HHPSIRPTLEGGK 42 (38)
2113.1201 2113.1288 64–85 FAEEADVVIVGAGPAGLSAAIR 68 (33)
1850592 Carnitine palmitoyl transferase 2 71262 (6.43) 49 21 of 27 520 958.4824 958.4782 383–389 FFNEVFR 40 (33)
1650.8552 1650.8850 168–182 AGLLEPEVFHLNPSK 77 (33)
1807.9280 1807.9337 64–78 YLNAQKPLLDDSQFR 73 (33)
2484.2603 2484.2293 275–296 YILSDSSPVPEFPVAYLTSENR 112 (33)
2392291 Enoyl-CoA hydratase chain A 28287 (6.41) 36 11 of 25 160 1311.6677 1311.6593 87–96 FLSHWDHITR 20 (37)
2111.1326 2111.1244 129–149 AQFGQPEILLGTIPGAGGTQR 74 (37)
51948476 Complex III, core protein 1 49380 (5.22) 10 8 of 19 165 1580.7802 1580.7856 86–99 NNGAGYFLEHLAFK 78 (32)
1646.8246 1646.8133 112–126 EVESIGAHLNAYSTR 37 (32)
14192933 ALDH2 54368 (5.69) 9 8 of 12 180 1470.7606 1470.7628 397–409 GYFIQPTVFGDVK 72 (39)
1531.7502 1531.7428 162–174 TIPIDGDFFSYTR 27 (34)
1775.8210 1775.8123 327–340 TFVQEDVYDEFVER 58 (34)
57527204 Electron-transferring ﬂavoprotein α polypeptide 34929 (8.62) 31 12 of 25 437 1662.7885 1662.7976 188–203 APSSSSAGISEWLDQK 118 (38)
1794.0237 1794.0265 86–101 GLLPEELTPLILETQK 72 (38)
1812.9580 1812.9609 233–249 LLYDLADQLHAAVGASR 89 (38)
1920.9028 1920.9127 250–268 AAVDAGFVPNDMQVGQTGK 73 (38)
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Table S2 Continued
Candidate MS data Supporting tandem MS data
NCBInr ‘gI’ % Sequence Peptide matches MASCOT Mass (MH+) MASCOT
accession Protein name MM (pI) coverage at 25 p.p.m./supplied PMF score Observed calculated Residues Sequence score (P <0.05)
6978431 Long chain acyl-CoA dehydrogenase 44672 (6.26) 33 12 of 35 272 1250.5932 1250.6164 52–61 IFSSEHDIFR 77 (37)
1406.7296 1406.7175 51–61 RIFSSEHDIFR 33 (37)
1540.7471 1540.7278 255–267 AQDTAELFFEDVR 97 (37)
1673.7982 1673.7992 280–292 GFYYLMQELPQER 41 (38)
20304123 3-Mercaptopyruvate sulfurtransferase 32809 (5.88) 28 14 of 20 277 1221.6252 1221.6335 283–293 AQPEHVISQGR 39 (39)
1358.6824 1358.6852 53–64 HIPGAAFFDIDR 50 (39)
1425.6897 1425.6968 165–176 THEDILENLDAR 52 (39)
1599.7974 1599.8027 119–133 AFGHHSVSLLDGGFR 38 (39)
149036390 Mitoﬁlin 83484 (6.18) 27 25 of 35 391 1271.5773 1271.5790 486–495 FEFEQDLSEK 42 (32)
1287.6494 1287.6328 496–505 LSEQELEFHR 38 (32)
1823.8929 1823.8882 527–543 GIEQAVQSHAVAEEEAR 101 (32)
18426858 Succinate dehydrogenase, subunit A ﬂavoprotein 68004 (6.17) 29 22 of 45 478 1122.5885 1122.5902 243–253 NTIIATGGYGR 39 (39)
1318.7384 1318.7365 629–639 VTLDYRPVIDK 42 (39)
1329.6759 1329.6757 305–317 GEGGILINSQGER 76 (39)
1354.7200 1354.7226 188–199 TGHSLLHTLYGR 57 (39)
1473.8397 1473.8424 444–457 LGANSLLDLVVFGR 84 (39)
2167.1306 2167.1407 354–371 DHVYLQLHHLPPEQLATR 53 (39)
62079055 Isocitrate dehydrogenase (NADP+) mitochondrial 46640 (8.49) 20 11 of 46 96 903.4569 903.4472 283–288 IWYEHR 20 (37)
976.5684 976.5575 141–149 NILGGTVFR 38 (37)
11968090 Short-chain acyl-CoA dehydrogenase 42187 (6.38) 15 7 of 18 73 1260.6730 1260.6616 316–327 LADMALALESAR 42 (39)
3915779 Myosin heavy chain 6 223488 (5.68) 27 30 of 39 432 1030.5499 1030.5891 1240–1248 EALISQLTR 36 (37)
1081.4875 1081.5273 1214–1222 SLNDFTTQR 57 (37)
1090.5449 1090.5891 1506–1514 AQLEFNQIK 41 (37)
1151.5863 1151.6280 1272–1282 NALAHALQSAR 72 (37)
1238.5234 1238.5648 1196–1205 TLEDQANEYR 64 (37)
1428.7229 1428.7693 1623–1634 NTLLQAELEELR 90 (37)
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Figure S1 UV photolysis of S-nitrosated mitochondrial protein thiols
To further ensure the speciﬁcity of PrSNO reduction by Cu(II) and ascorbate and labelling by
ﬂuorescent maleimide dyes, UV photolysis of PrSNOs was employed. As anticipated, treatment
with MitoSNO followed by NEM blocking of free protein thiols and reduction of PrSNOs
by Cu(II) and ascorbate in the presence of a ﬂuorescent maleimide dye (lane 2) resulted in
signiﬁcant labelling when compared with the no MitoSNO control (lane 1). UV photolysis of
PrSNOs following MitoSNO treatment but before NEM blocking of free thiols resulted in a
time-dependent loss of the ﬂuorescent signal (lanes 3 and 4). Alternatively, employing UV
photolysis instead of Cu(II) and ascorbate reduction of PrSNOs following NEM blocking (lanes
5 and 6) resulted in a very similar ﬂuorescent signal to the reduction conditions used in the
DIGE analysis (lane 2).
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Figure S2 A typical Coomassie Blue-stained gel
The red circles indicate the protein spots that showed signiﬁcant changes in the SNO-DIGE and/or Redox-DIGE analyses and were analysed by MS. The identities of the proteins are listed beside the
gel image. For detailed MALDI–TOF-TOF data, see Table S2. MW, molecular mass.
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Figure S3 Additional functional characterization of S-nitrosation by
MitoSNO
Metabolic enzymes found to be S-nitrosated and inhibited due to MitoSNO action were
tested for reversibility with DTT and effects due to the mitochondrial targeting moeity.
(A)Mitochondrialaconitaseactivitywasfoundtodecrease,beginning5minfollowingMitoSNO
treatment and showing signiﬁcant inhibition beyond 10 min when compared with vehicle
treated and MitoNAP-treated controls. Addition of DTT to reduce modiﬁcations following
treatment with MitoSNO completely reversed the inhibitory effect. (B) α-KGDH activity was
also inhibited by MitoSNO action, causing signiﬁcant inhibition 20 min following MitoSNO
addition. The inhibitory effect of MitoSNO was reversed with DTT. (C) MitoSNO signiﬁcantly
inhibited mitochondrial ALDH2 5 min following its addition and onwards, and the inhibitory
effectwascompletelyreversedbyDTT.Errorbarsshowmeans+ −S.E.M.;*P <0.05;**P <0.01
by Student’s t test.
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